Literature DB >> 26400236

In vivo cardiac reprogramming using an optimal single polycistronic construct.

Hong Ma1, Li Wang1, Chaoying Yin1, Jiandong Liu2, Li Qian2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26400236      PMCID： PMC4614689          DOI： 10.1093/cvr/cvv223

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  16 in total

1.  A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.

Authors:  Stephanie Protze; Shahryar Khattak; Claire Poulet; Dirk Lindemann; Elly M Tanaka; Ursula Ravens
Journal:  J Mol Cell Cardiol       Date:  2012-04-28       Impact factor: 5.000

2.  Reprogramming of human fibroblasts toward a cardiac fate.

Authors:  Young-Jae Nam; Kunhua Song; Xiang Luo; Edward Daniel; Kaleb Lambeth; Katherine West; Joseph A Hill; J Michael DiMaio; Linda A Baker; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

3.  Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.

Authors:  Kohei Inagawa; Kazutaka Miyamoto; Hiroyuki Yamakawa; Naoto Muraoka; Taketaro Sadahiro; Tomohiko Umei; Rie Wada; Yoshinori Katsumata; Ruri Kaneda; Koji Nakade; Chitose Kurihara; Yuichi Obata; Koichi Miyake; Keiichi Fukuda; Masaki Ieda
Journal:  Circ Res       Date:  2012-08-28       Impact factor: 17.367

4.  Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming.

Authors:  Li Wang; Ziqing Liu; Chaoying Yin; Huda Asfour; Olivia Chen; Yanzhen Li; Nenad Bursac; Jiandong Liu; Li Qian
Journal:  Circ Res       Date:  2014-11-21       Impact factor: 17.367

5.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

Authors:  Masaki Ieda; Ji-Dong Fu; Paul Delgado-Olguin; Vasanth Vedantham; Yohei Hayashi; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

6.  Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.

Authors:  Jenny X Chen; Markus Krane; Marcus-Andre Deutsch; Li Wang; Moshe Rav-Acha; Serge Gregoire; Marc C Engels; Kuppusamy Rajarajan; Ravi Karra; E Dale Abel; Joe C Wu; David Milan; Sean M Wu
Journal:  Circ Res       Date:  2012-05-10       Impact factor: 17.367

7.  Heart repair by reprogramming non-myocytes with cardiac transcription factors.

Authors:  Kunhua Song; Young-Jae Nam; Xiang Luo; Xiaoxia Qi; Wei Tan; Guo N Huang; Asha Acharya; Christopher L Smith; Michelle D Tallquist; Eric G Neilson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  Nature       Date:  2012-05-13       Impact factor: 49.962

8.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.

Authors:  Li Qian; Yu Huang; C Ian Spencer; Amy Foley; Vasanth Vedantham; Lei Liu; Simon J Conway; Ji-dong Fu; Deepak Srivastava
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

9.  Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.

Authors:  Nicolas Christoforou; Malathi Chellappan; Andrew F Adler; Robert D Kirkton; Tianyi Wu; Russell C Addis; Nenad Bursac; Kam W Leong
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.

Authors:  Megumi Mathison; Robert P Gersch; Ahmed Nasser; Sarit Lilo; Mallory Korman; Mitchell Fourman; Neil Hackett; Kenneth Shroyer; Jianchang Yang; Yupo Ma; Ronald G Crystal; Todd K Rosengart
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501
View more
  25 in total

1.  ErbB2 is required for cardiomyocyte proliferation in murine neonatal hearts.

Authors:  Hong Ma; Chaoying Yin; Yingao Zhang; Li Qian; Jiandong Liu
Journal:  Gene       Date:  2016-07-04       Impact factor: 3.688

2.  Initiating Events in Direct Cardiomyocyte Reprogramming.

Authors:  Kimberly Sauls; Todd M Greco; Li Wang; Meng Zou; Michelle Villasmil; Li Qian; Ileana M Cristea; Frank L Conlon
Journal:  Cell Rep       Date:  2018-02-13       Impact factor: 9.423

Review 3.  Direct Cardiac Cellular Reprogramming for Cardiac Regeneration.

Authors:  Vivekkumar Patel; Megumi Mathison; Vivek P Singh; Jianchang Yang; Todd K Rosengart
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-09

4.  Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction.

Authors:  Hong Ma; Li Wang; Jiandong Liu; Li Qian
Journal:  Methods Mol Biol       Date:  2017

Review 5.  Improving cardiac reprogramming for heart regeneration.

Authors:  Liu Liu; Ienglam Lei; Zhong Wang
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

6.  Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming.

Authors:  Haley Ruth Vaseghi; Chaoying Yin; Yang Zhou; Li Wang; Jiandong Liu; Li Qian
Journal:  Genesis       Date:  2016-06-01       Impact factor: 2.487

Review 7.  Direct cardiac reprogramming comes of age: Recent advance and remaining challenges.

Authors:  Yifang Xie; Jiandong Liu; Li Qian
Journal:  Semin Cell Dev Biol       Date:  2021-07-23       Impact factor: 7.727

8.  In Vitro Conversion of Murine Fibroblasts into Cardiomyocyte-Like Cells.

Authors:  Jun Xu; Li Wang; Jiandong Liu; Li Qian
Journal:  Methods Mol Biol       Date:  2021

Review 9.  Translational perspectives on cardiac reprogramming.

Authors:  Young-Jae Nam
Journal:  Semin Cell Dev Biol       Date:  2021-06-29       Impact factor: 7.727

10.  Down-regulation of Beclin1 promotes direct cardiac reprogramming.

Authors:  Li Wang; Hong Ma; Peisen Huang; Yifang Xie; David Near; Haofei Wang; Jun Xu; Yuchen Yang; Yangxi Xu; Tiffany Garbutt; Yang Zhou; Ziqing Liu; Chaoying Yin; Michael Bressan; Joan M Taylor; Jiandong Liu; Li Qian
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.